Daniel Stover, MD, FASCO (@stoverlab) 's Twitter Profile
Daniel Stover, MD, FASCO

@stoverlab

Inactive - find me @stoverlab.bsky.social

ID: 806257453088305152

linkhttps://u.osu.edu/stoverlab calendar_today06-12-2016 22:02:11

4,4K Tweet

5,5K Followers

1,1K Following

Christian Rolfo (@christianrolfo) 's Twitter Profile Photo

Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers | Cancer Discovery | American Association for Cancer Research ⁦Cancer Discovery⁩ ⁦International Society of Liquid Biopsy⁩ aacrjournals.org/cancerdiscover…

Ruth Keri (@ruthkeri2) 's Twitter Profile Photo

Ask your lawmakers to support the Metastatic Breast Cancer (MBC) Access to Care Act, so those living with MBC do not have to wait for the treatments and financial support they require. The time to take action is now! p2a.co/mYuC11r #KomenAdvocacy

Daniel Stover, MD, FASCO (@stoverlab) 's Twitter Profile Photo

Great discussion of recent American Cancer Society data, @DrGattiMays! ✅Breast cancer deaths are declining-great news. Points to progress in screening but importantly new/improved treatments. ‼️More needs to be done for young women & those of AAPI & Black/African-American background!

Dionisia Quiroga, DO, PhD (@quirogad) 's Twitter Profile Photo

📣Had a great discussion this week ASCO Daily News w/ Drs Charlotte Coles & Walter Weber on breast cancer locoregional tx updates #bcsm ✂️When can we omit ALND &/or SLNB? 💪How can we better prevent lymphedema? ☢️How can hypofractioned RT improve pt QOL? dailynews.ascopubs.org/do/podcast-per…

Daniel Stover, MD, FASCO (@stoverlab) 's Twitter Profile Photo

Still so many clinical challenges in the management of metastatic ER+/HER2- #breastcancer. Looking forward to this great Case-Based Educational Session moderated by Sara Hurvitz w Mike Oliphant Aditya Bardia, MD Neil Vasan & patient voice Amy Beumer, Ph.D. ! The James Ohio State Medical Oncology

Christian Rolfo (@christianrolfo) 's Twitter Profile Photo

Our Early Drug Development Unit it’s a brand new facility advancing the knowledge of new drugs and giving patients access to clinical trials. Great team from doctors, nurses, lab, research to administration working for our patients. The James Ohio State Medical Oncology The Ohio State University Wexner Medical Center

Our Early Drug Development Unit it’s a brand new facility advancing the knowledge of new drugs and giving patients access to clinical trials. Great team from doctors, nurses, lab, research to administration working for our patients. <a href="/OSUCCC_James/">The James</a> <a href="/OhioStateMedOnc/">Ohio State Medical Oncology</a> <a href="/OSUWexMed/">The Ohio State University Wexner Medical Center</a>
Sara Tolaney (@stolaney1) 's Twitter Profile Photo

Incredible to have Daniel Stover, MD, FASCO giving a keynote lecture at the Harvard Breast and Gynecologic Cancer Symposium- what a thoughtful and practical approach to translational research in breast cancer

Incredible to have <a href="/StoverLab/">Daniel Stover, MD, FASCO</a> giving a keynote lecture at the Harvard Breast and Gynecologic Cancer Symposium-  what a thoughtful and practical approach to translational research in breast cancer
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

The DF/HCC Breast & Gynecologic Cancer Symposium started off with the J. Dirk Iglehart, M.D., Visiting Scholar Lecture given by Dr. Daniel Stover (Daniel Stover, MD, FASCO) who discussed Translational Cancer Research: Data is the Answer and the Question. dfhcc.harvard.edu/events/dfhcc-b…

The <a href="/df_hcc/">DF/HCC</a> Breast &amp; Gynecologic Cancer Symposium started off with the J. Dirk Iglehart, M.D., Visiting Scholar Lecture given by Dr.  Daniel Stover (<a href="/StoverLab/">Daniel Stover, MD, FASCO</a>) who discussed Translational Cancer Research: Data is the Answer and the Question.
dfhcc.harvard.edu/events/dfhcc-b…
Daniel Stover, MD, FASCO (@stoverlab) 's Twitter Profile Photo

We are very excited to welcome Kimryn Rathmell as our next CEO The James! Brilliant physician-scientist, talented administrator, dedicated mentor - we are so excited for what is to come!

Christine Hodgdon (@christeeny513) 's Twitter Profile Photo

Even HP was not tolerable for me as maintenance treatment for HER2+ MBC. The patient community calls Perjeta “poo-jeta” for a reason! Indefinite T-DxD is not realistic- survivors will have to contend with long term SEs of ADCs (think ❤️& liver fx) #ASCO25 #bcsm